In brief
  • A 21 August 2026 review reexamined bakuchiol next to retinol and asked for clearer labels.
  • The 2019 trial tested 0.5% bakuchiol twice daily against 0.5% retinol once daily for 12 weeks in 44 people.
  • Wrinkle area and dark spots improved in both groups, while scaling and stinging were higher with retinol.

44 people. That is the size of the head to head trial behind a new evidence review published 21 August 2026 by AutyFIT Editorial, which revisits bakuchiol as a retinol alternative. The review asks brands and shelves to use plainer language about what was tested.

If nightly retinol leaves your skin red or flaky, the takeaway is narrow but practical. The most studied comparison found similar improvement in photoageing signs with easier tolerance for bakuchiol. That finding applies to one tested routine only. It does not turn each bakuchiol serum into a match for retinol.

The starting point is the plant source. Bakuchiol is a meroterpene phenol from the seeds and leaves of Psoralea corylifolia, also called Cullen corylifolium. Seed oil, a dilute extract and high purity bakuchiol are separate raw materials. A Pierre Fabre study from 2020 reported its bakuchiol raw material at about 95 percent purity.

The trial was tight and exact. If you want to track it in your routine log, it was listed on ClinicalTrials.gov as NCT03112863. For timing context, it tested 0.5 percent bakuchiol twice daily against 0.5 percent retinol once daily for 12 weeks in 44 participants. Both arms showed significant drops in wrinkle surface area and hyperpigmentation, with no statistical gap between compounds on those measures. To judge whether your routine is doing anything, one summary framed the shift as 20 to 30 percent reductions in fine lines and hyperpigmentation.

Tolerance is where the two evening routines diverged. When you choose what to take and what to space apart, people assigned to retinol noted more facial scaling and stinging than people assigned to bakuchiol. In 2019 Chaudhuri and Bojanowski wrote in the British Journal of Dermatology that bakuchiol matches retinol for improving photoageing and is tolerated better.

The science behind the interest stays modest when read closely. Retinol changes into retinoic acid in skin and attaches to retinoid receptors, while bakuchiol does not change into retinoic acid. Gene expression work from 2014 found bakuchiol switched on downstream collagen supporting pathways while holding back MMPs that degrade collagen. Later reviews land in a similar place. To guide stacking and nightly use, a review in the Journal of Integrative Dermatology searched PubMed and EMBASE for bakuchiol and photoaging, kept seven articles from 2014 to 2021, and concluded bakuchiol demonstrated comparable efficacy and better tolerability than retinol when tested side by side. A 2024 comparative study in the Journal of Cosmetic Dermatology found similar results for photoaging and hyperpigmentation after 12 weeks with fewer reports of redness and scaling.

What to track next is sourcing and strength. The head to head used separate schedules, so it compared routines rather than gram for gram potency. Product copy often folds cell, animal and human results into a single studies show statement, which claims more than cosmetic trials measured. When you plan your habit, note a 2025 market analysis by Grand View Research projected the global bakuchiol market to grow at a compound annual growth rate of 7.5 percent through 2030, so expect more formulas with less clarity.

For now, view bakuchiol as one steady option for sensitive evening routines, not a full swap for every retinoid result.

Written by

Rachel Chandler

Rachel runs the news desk and the routine guides at The Daily Capsule. She checks every timing tip against the label and keeps a seven-day pill organizer on her desk as a reminder of who the guides are for.

More from Rachel Chandler →